TXG Sale Disclosure
Taich Adam · SEC Form 4 · Filed Sep 11, 2026
Sale
Calculated transaction value
$76.79K
Taich Adam Chief Financial Officer
TXG
10x Genomics
TXG
Transaction date
Sep 9, 2026
Public filing date
Sep 11, 2026
Filing lag
Filed 2 days later
TXG daily price context
Close on/before transaction
$67.29
Sep 9, 2026
Close before public filing
$66.38
Sep 10, 2026
Return since public filing
+4.16%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 1,206 shares @ $63.68
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001610717-26-000414
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$3M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| 10x Genomics, Inc. TXG | Sale | Sep 9, 2026 | $897.55K |
| 10x Genomics, Inc. TXG Current | Sale | Sep 9, 2026 | $76.79K |
| 10x Genomics, Inc. TXG | Sale | Sep 9, 2026 | $2.02M |